Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage

Yuhua Zhang1, Qiaojun Fang1, Hongfeng Wang2

  • 1State Key Laboratory of Bioelectronics, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, Jiangsu, China.

Autophagy
|April 26, 2022
PubMed

Insights

Aminoglycoside ototoxicity impairs mitophagy, a cellular process that removes damaged mitochondria. Activating mitophagy can protect hair cells from this damage, suggesting a potential therapy for hearing loss.

Area of Science:

  • Cell Biology
  • Otolaryngology
  • Mitochondrial Biology

Background:

  • Aminoglycosides cause ototoxicity by damaging mitochondria, leading to hair cell death and hearing loss.
  • Mitophagy is a crucial mitochondrial quality control pathway for cell survival.
  • The role of mitophagy in aminoglycoside-induced hair cell injury remains unclear.

Purpose of the Study:

  • To investigate the role of mitophagy in neomycin-induced hair cell injury.
  • To elucidate the molecular mechanisms by which neomycin affects mitophagy.
  • To explore the therapeutic potential of mitophagy modulation for aminoglycoside ototoxicity.

Main Methods:

  • Neomycin treatment of hair cells.
  • Assessment of mitophagy using PINK1-PRKN pathway markers.
  • Measurement of mitophagic flux with mt-mKeima reporter.
  • Analysis of Pink1 and ATF3 expression levels.
  • Evaluation of mitophagy activator efficacy in rescuing hair cells.

Main Results:

  • Neomycin treatment impaired PINK1-PRKN-mediated mitophagy in hair cells.
  • Mitochondrial recruitment of PRKN and phagophore recognition were blocked.
  • Lysosomal degradation of damaged mitochondria decreased, as shown by reduced mitophagic flux.
  • Neomycin inhibited Pink1 expression transcriptionally and induced ATF3 expression.
  • Mitophagy activator treatment rescued neomycin-damaged hair cells.

Conclusions:

  • Dysregulation of PINK1-PRKN-mediated mitophagy contributes to aminoglycoside-induced hair cell injury.
  • Neomycin disrupts mitophagy via transcriptional inhibition of Pink1 and induction of ATF3.
  • Therapeutic strategies targeting mitophagy activation may offer a novel approach to prevent or treat aminoglycoside-induced hearing loss.